Trabedersen

Trabedersen (AP 12009) is an antisense oligodeoxynucleotide that specifically inhibits TGF-β2 (TGF-beta/Smad) . Trabedersen can be used for the study of malignant brain tumors and other solid tumors overexpressing TGF-β2, such as those of the skin, pancreas and colon[1][2].

Product Specifications

CAS Number

[925681-61-4]

Product Name Alternative

AP 12009

UNSPSC

12352208

Target

TGF-beta/Smad

Type

Oligonucleotides

Related Pathways

Stem Cell/Wnt; TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/trabedersen.html

Purity

90.45

Solubility

H2O : 100 mg/mL (ultrasonic)

Smiles

[Trabedersen]

Molecular Formula

C177H225N60O94P17S17

Molecular Weight

5768.70

References & Citations

[1]Luc Vallières. Trabedersen, a TGFbeta2-specific antisense oligonucleotide for the treatment of malignant gliomas and other tumors overexpressing TGFbeta2. IDrugs. 2009 Jul;12 (7) :445-53.|[2]Karl-Hermann Schlingensiepen, et al. Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. Cancer Sci. 2011 Jun;102 (6) :1193-200.